Navigation Links
BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
Date:11/22/2011

PRINCETON, New Jersey, November 22, 2011 /PRNewswire/ --

CitiusTech announced today that its BI-Clinical platform for healthcare business intelligence and advanced analytics supports all ACO quality measures that are part of the ACO final rule released by CMS on October 20, 2011.

BI-Clinical can now help ACO participants assess and report performance and quality of care, across all four domains - patient / caregiver experience, care coordination / patient safety, preventive health and at-risk population. With customizable interfaces, gaps-in-care reports, clinical alerts and comparative care-cost benchmarking, BI-Clinical enables ACOs to effectively manage quality of care for its patients, at both the individual as well as population level. BI-Clinical's flexible Clinical Measure Processing Engine enables ACOs to modify clinical measures and create new measures to effectively manage performance.

Dennis Swarup, Business Director at CitiusTech, highlighted, "Most ACOs will include hospitals with different EMRs, clinical applications, revenue cycle applications and financial systems. BI-Clinical's ability to support both claim and EHR data in a multi-vendor environment is key to addressing the ACOs' cross-enterprise reporting and performance management needs."

BI-Clinical has strong professional services partners across North America, who enable ACO participants to define their overall BI/analytics and reporting strategy for all stakeholders. Our partners also implement BI-Clinical and integrate the platform with ACO and hospital IT environments.

About BI-Clinical

CitiusTech's BI-Clinical is a modular, scalable and interoperable platform for healthcare BI, analytics and regulatory compliance. With over 600 pre-built measures and KPIs for clinical, financial, operational and regulatory reporting, BI-Clinical ensures 100% coverage of all Meaningful Use, PQRS, HEDIS, JCAHO and ACO quality reporting measures. BI-Clinical 10.3 is
'/>"/>

SOURCE CitiusTech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Novel monoclonal antibody offers potential treatment for tumors resistant to VEGF therapy
2. Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research
3. New report offers broad approach to assessing impacts of ecological damage
4. Evolution offers clues to leading cause of death during childbirth
5. Fiery volcano offers geologic glimpse into land that time forgot
6. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users
7. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform™ That Offers Unparalleled Flexibility to End-Users
8. New technology offers the next generation of mammography
9. New class of stem cell-like cells discovered offers possibility for spinal cord repair
10. Novel drug combination offers therapeutic promise for hard-to-treat cancers
11. Research offers means to detoxify mycotoxin-contaminated grain intended for ethanol, animal feed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... the popular attention of both children and aquarium hobbyists ... as dehydrated eggs, these tiny brine shrimp readily hatch, ... of salt water. , Physicists, though, are interested ... vertically migrate in large groups in response to changing ... and retreating deeper during the day. , Two researchers ...
(Date:9/30/2014)... Medicine reports positive results of a phase 1 ... of lung cancer marked by rearrangement of the gene ... advanced non-small cell lung cancer testing positive for ROS1 ... 3 complete responses and 33 partial responses. Median progression-free ... to resume its growth after being slowed by treatment ...
(Date:9/30/2014)... Ludwig-Maximilians-Universitaet (LMU) in Munich report that a new ... sensitive to chemotherapeutic drugs. They have also pinpointed ... target for anti-tumor agents. , Researchers led ... Sieber of the Technische Universitt Mnchen have identified ... new weapon in the fight against malignant tumors. ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2NEJM: Crizotinib effective in Phase 1 trial against ROS1 lung cancer 2Cancer therapy: Driving cancer cells to suicide 2
... engine is far from easy. Due to the turbulent ... are the same. Furthermore, the measurements are difficult to ... into the cylinder causes an extra source of turbulence. ... an engine adapted for this purpose. Laser Induced ...
... that a protein known as PEPT2 protects the brains ... toxic compound present in lead poisoning and in a ... neurological complications. Scientists at the University of ... 5-aminolevulinic acid (5-ALA), mice without the PEPT2 protein died ...
... United States Department of Agriculture (USDA) recently examined the ... production of packaged produce. The study, published in the ... learn more about how industry practices affect quality and ... Food Technologist at the United States Department of Agriculture,s ...
Cached Biology News:Fresh-cut produce washing practices can minimize food-borne illness risks 2
(Date:10/2/2014)... 2014  CSSi ( www.CSSiEnroll.com ), the leader ... industry, is pleased to announce its participation in ... October.  President Chris Trizna will be ... Clinical Trials New England conference sponsored by Arena ... annual Site Solutions Summit sponsored by the Society ...
(Date:10/2/2014)... and BRIDGEWATER, N.J. , ... , a leader in synthetic biology, and ... drug manufacturer by volume in the U.S., today ... Collaboration (ECC) for a target active pharmaceutical ingredient ... goal of the collaboration is to develop a ...
(Date:10/1/2014)... What: , Cambridge Semantics, the leading provider ... technology, today announced its participation in the 2014 Big ... Data solutions provide semantic linkage and meaning to Big ... and manage diverse data. Ben Szekely, vice president and ... a “life sciences data lake” and an approach for ...
(Date:10/1/2014)... 1, 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO) ... a Phase II Small Business Innovation Research Grant ... the National Institute of Allergy and Infectious Diseases ... to support the development of the Company,s aerosolized ... to mitigate acute and chronic/late-phase radiation-induced lung injury. ...
Breaking Biology Technology:Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 3Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... 10 Beckman Coulter, Inc. (NYSE: BEC ... that simplify, automate, and innovate complex biomedical testing, will ... 2009, beginning at 10:00 a.m. (ET). The webcast ... www.beckmancoulter.com . To access the webcast select ...
... for the Treatment of EpilepsyBRANFORD, Conn., April 10 ... serious neurological and psychiatric disorders, today announced the close ... comes on the heels of the Company,s recent announcement ... adjunctive therapy in adults with partial onset seizures. The ...
... A University of California, San Diego bioengineer is the ... Science that provides insights on the "stickiness of ... organisms hailing from all limbs of the tree of ... example, the researchers outlined similar strategies across biology for ...
Cached Biology Technology:Marinus Pharmaceuticals Raises $20 Million in Series B Financing 2Marinus Pharmaceuticals Raises $20 Million in Series B Financing 3Marinus Pharmaceuticals Raises $20 Million in Series B Financing 4Marinus Pharmaceuticals Raises $20 Million in Series B Financing 5Life sticks: UC San Diego bioengineer's sticky insights published in journal Science 2Life sticks: UC San Diego bioengineer's sticky insights published in journal Science 3Life sticks: UC San Diego bioengineer's sticky insights published in journal Science 4
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: